Bots, editor, reviewer, Administrators
13,941
edits
No edit summary |
No edit summary |
||
Line 57: | Line 57: | ||
"BASALT" : "Best Adjustment Strategy for Asthma in the Long Term", | "BASALT" : "Best Adjustment Strategy for Asthma in the Long Term", | ||
"SMART" : "Isotonic Solutions and Major Adverse Renal Events Trial", | "SMART" : "Isotonic Solutions and Major Adverse Renal Events Trial", | ||
"AMAZES" : "Azithromycin on Asthma Exacerbations and Quality of Life in Adults With Persistent Uncontrolled Asthma", | |||
"POISE-2 ASA" : "Perioperative ischemic evaluation 2 aspirin arm", | "POISE-2 ASA" : "Perioperative ischemic evaluation 2 aspirin arm", | ||
"POINT" : "Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial", | "POINT" : "Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial", | ||
Line 180: | Line 181: | ||
"FEAST" : "Fluid Expansion as Supportive Therapy", | "FEAST" : "Fluid Expansion as Supportive Therapy", | ||
"TNT" : "Treating to New Targets", | "TNT" : "Treating to New Targets", | ||
"ACTT-1" : "Adaptive Covid-19 Treatment Trial", | |||
"DAVID" : "Dual-chamber pacing or ventricular backup pacing in ICD patients", | "DAVID" : "Dual-chamber pacing or ventricular backup pacing in ICD patients", | ||
"CAPRIE" : "Clopidogrel versus Aspirin in Patients at Risk of Ischaemic Events", | "CAPRIE" : "Clopidogrel versus Aspirin in Patients at Risk of Ischaemic Events", | ||
Line 233: | Line 235: | ||
"MIRACL" : "Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering", | "MIRACL" : "Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering", | ||
"NCDS" : "The National Cooperative Dialysis Study", | "NCDS" : "The National Cooperative Dialysis Study", | ||
"PARAGON-HF" : "Prospective Comparison of ARNI Global Outcomes in HF with Preserved Ejection Fraction", | |||
"ACTIVE W" : "Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events", | "ACTIVE W" : "Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events", | ||
"SEDCOM" : "Safety and Efficacy of Dexmedetomidine Compared with Midazolam", | "SEDCOM" : "Safety and Efficacy of Dexmedetomidine Compared with Midazolam", |